GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (XCNQ:BLAB) » Definitions » Construction In Progress

Britannia Life Sciences (XCNQ:BLAB) Construction In Progress : C$0.00 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Britannia Life Sciences Construction In Progress?


Britannia Life Sciences Construction In Progress Historical Data

The historical data trend for Britannia Life Sciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences Construction In Progress Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Construction In Progress
- - - -

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Britannia Life Sciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Britannia Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.
Executives
Peter James Shippen 10% Security Holder, Director, Senior Officer

Britannia Life Sciences Headlines

No Headlines